SCHEMBL2550792

SCHEMBL2550792

CCCCCP(CCCCC)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.38
SIGMAR1 Q99720 1/20 0.38
CES2 O00748 2/20 0.37
CES1 P23141 2/20 0.37
DNM1 Q05193 2/20 0.37
TSHR P16473 1/20 0.37
PCSK9 Q8NBP7 1/20 0.36
MEN1 O00255 1/20 0.36
TP53 P04637 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
EPHX2 P34913 1/20 0.36
PKM P14618 1/20 0.36
CYP3A4 P08684 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CETP P11597 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6288234 0.98 DNM1 (0.40) LTA4HSIGMAR1CES2CES1DNM1
SCHEMBL6288219 0.98 DNM1 (0.40) LTA4HSIGMAR1CES2CES1DNM1
SCHEMBL3813028 0.98 DNM1 (0.40) LTA4HSIGMAR1CES2CES1DNM1
SCHEMBL9493100 0.98 LTA4H (0.37) LTA4HSIGMAR1CES2CES1DNM1
SCHEMBL15659895 0.98 DNM1 (0.40) LTA4HSIGMAR1CES2CES1DNM1
SCHEMBL49664 0.98 DNM1 (0.40) LTA4HSIGMAR1CES2CES1DNM1
SCHEMBL6288242 0.98 DNM1 (0.40) LTA4HSIGMAR1CES2CES1DNM1
Hydrochloric Acid SCHEMBL29193919 0.98 LTA4H (0.37) LTA4HSIGMAR1CES2CES1DNM1
SCHEMBL6288656 0.98 DNM1 (0.40) LTA4HSIGMAR1CES2CES1DNM1
SCHEMBL2922719 0.98 DNM1 (0.40) LTA4HSIGMAR1CES2CES1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167144-A1 PREPARATION AND ITS APPLICATION OF A CYANIDE-BRIDGED METAL ORGANIC COMPOUND WITH INTRAMOLECULAR MAGNETIC TRANSFORMATION Hubei Jingmen Industrial Technology Research Institute Co., Ltd. (CN) 2023-06-01 US claimed
EP-1252551-B1 PHOTOINITIATOR SYSTEM WITH ACYLPHOSPHINE OXIDE INITIATORS S & C POLYMER SILICON & COMPOS (DE) 2006-07-19 EP claimed
WO-2024098840-A1 ISOBUTYLENE-BASED CATIONIC SALT POLYMER, PREPARATION METHOD THEREFOR, USE THEREOF, AND ANTIBACTERIAL POLYMER MATERIAL 中国石油化工股份有限公司 2024-05-16 WO disclosed
CN-118027253-A Isobutenyl quaternary phosphonium salt ionic polymer, preparation method and application thereof, and antibacterial high polymer material 中国石油化工股份有限公司 2024-05-14 CN disclosed
CN-115746403-B Composite flame retardant for rubber and preparation method thereof 山东亚荣化学股份有限公司 2023-11-03 CN disclosed
US-20230167144-A1 PREPARATION AND ITS APPLICATION OF A CYANIDE-BRIDGED METAL ORGANIC COMPOUND WITH INTRAMOLECULAR MAGNETIC TRANSFORMATION Hubei Jingmen Industrial Technology Research Institute Co., Ltd. (CN) 2023-06-01 US disclosed
EP-2735581-B1 COMPOSITION AND POLYMER ASAHI CHEMICAL IND (JP) 2021-07-14 EP disclosed
EP-2990112-B1 METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE MARUZEN PETROCHEM CO LTD (JP) 2020-03-25 EP disclosed
EP-2990113-B1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS MARUZEN PETROCHEM CO LTD (JP) 2020-03-25 EP disclosed
US-10029241-B2 Method for producing catalyst for cyclic carbonate synthesis MARUZEN PETROCHEMICAL CO., LTD. (JP) 2018-07-24 US disclosed
US-10011621-B2 Method for producing silica gel-immobolized phosphonium salt catalysts MARUZEN PETROCHEMICAL CO., LTD. (JP) 2018-07-03 US disclosed
EP-0046330-A2 Process for the preparation of nickel ylides containing sulfonated group V ligands GULF RESEARCH & DEVELOPMENT COMPANY (US) 1982-02-24 EP disclosed
EP-0046329-A1 Process for the oligomerization of ethylene GULF RESEARCH & DEVELOPMENT COMPANY (US) 1982-02-24 EP disclosed
US-4310716-A NICKEL YLIDE CATALYST GULF RESEARCH & DEVELOPMENT COMPANY (US) 1982-01-12 US disclosed
US-4301318-A OBTAINED BY REACTING ETHYLENE USING A NICKEL YLIDE CATALYST; SOLVENT EXTRACTION OF CATALYST USING AMMONIUM HYDROXIDE GULF RESEARCH & DEVELOPMENT COMPANY (US) 1981-11-17 US disclosed
US-4293727-A CATALYSIS WITH NICKEL YLIDE GULF RESEARCH & DEVELOPMENT COMPANY (US) 1981-10-06 US disclosed
US-4293502-A CATALYST FOR OLIGOMERIZATION OF ETHYLENE GULF RESEARCH & DEVELOPMENT COMPANY (US) 1981-10-06 US disclosed
US-4267383-A USING A COMPLEX CATALYST FROM A TRIARYL PHOSPHINE AND A RHODIUM CARBONYL HYDRIDE OR CHLORIDE CELANESE CORPORATION (US) 1981-05-12 US disclosed
US-4257973-A USING ORGANOPHOSPHORUS-PALLADIUM HALIDE COORDINATION CATALYST E. I. DU PONT DE NEMOURS AND COMPANY (US) 1981-03-24 US disclosed
US-3965192-A Hydrocarbonylation process UNION OIL COMPANY OF CALIFORNIA (US) 1976-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10029241-B2 Method for producing catalyst for cyclic carbonate synthesis CYCS, CA7, CA9 LTA4H 912/4885SIGMAR1 3984/4885CES2 314/4885
US-10011621-B2 Method for producing silica gel-immobolized phosphonium salt catalysts SIK2, SIK3, SIK1 LTA4H 3307/4885SIGMAR1 77/4885CES2 662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.